GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Statera BioPharma Inc (STU:7CB) » Definitions » Additional Paid-In Capital

Statera BioPharma (STU:7CB) Additional Paid-In Capital : €134.86 Mil(As of Sep. 2022)


View and export this data going back to 2021. Start your Free Trial

What is Statera BioPharma Additional Paid-In Capital?


Statera BioPharma's quarterly additional paid-in capital increased from Mar. 2022 (€122.15 Mil) to Jun. 2022 (€126.26 Mil) and increased from Jun. 2022 (€126.26 Mil) to Sep. 2022 (€134.86 Mil).

Statera BioPharma's annual additional paid-in capital increased from Dec. 2019 (€10.18 Mil) to Dec. 2020 (€19.68 Mil) and increased from Dec. 2020 (€19.68 Mil) to Dec. 2021 (€113.05 Mil).


Statera BioPharma Additional Paid-In Capital Historical Data

The historical data trend for Statera BioPharma's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Statera BioPharma Additional Paid-In Capital Chart

Statera BioPharma Annual Data
Trend Dec19 Dec20 Dec21
Additional Paid-In Capital
10.18 19.68 113.05

Statera BioPharma Quarterly Data
Dec19 Mar20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22
Additional Paid-In Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 107.29 113.05 122.15 126.26 134.86

Statera BioPharma Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

Statera BioPharma Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Statera BioPharma's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.


Statera BioPharma (STU:7CB) Business Description

Traded in Other Exchanges
N/A
Address
4333 Corbett Drive, Suite 1082, Fort Collins, CO, USA, 80525
Statera BioPharma Inc is a pre-clinical and clinical biopharmaceutical company developing multiple product candidates to address unmet medical needs for use in diseases involving immune system dysfunction.

Statera BioPharma (STU:7CB) Headlines

No Headlines